Life Science ETFs Performance 2018-2019: FBT is the Leader…Updates 2/7

http://www.nailsbykimchau.com/72784-proscar-uk.html reason by | Feb 4, 2019 | 2009-2017 Life Science Portfolios, 2018 Rayno Biopharmaceuticals Portfolio, Clinical Diagnostics and Tools

Update 2/7/19 Mid-Day Trading : Risk Off Day The market is trending down with all major indices in the red and the XBI $81.96 down 2.75%. We sold our position in the XBI yesterday at $83+. Array (ARRY) continues to run up at $21.60. Hot stock MacroGenics (MGNX) cooled...

Bull Case for Biotech Remains Elusive-Trade Carefully…Update after FED Meeting

https://www.safeglassbottle.customcondomsfactory.com/96203-lantus-cost.html differentiate by | Dec 13, 2018 | 2018 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro

Update-2 After close: Market Collapses After FED Meeting-Bear Market  WE all knew that the biotech sector likes looser monetary policy but this sell-off is ridiculous. The IBB is now at May 2017 levels! XBI breaks through 2018 technicals down 3.33% on downside to...

Pin It on Pinterest